Table 5: Adverse events.

Initially no fistula ( )Preexisting fistula ( )Any fistula overall ( ) value (any fistula versus no fistula)
No fistula overall ( )Fistula during NPWT ( )Fistula after NPWT ( )

Death28.6% (13)40.0% (2)25.0% (1)34.6% (9)34.3% (12)0.63
Bleeding15.2% (7)0.0% (0)25.0% (1)3.9% (1)5.7% (2)0.29
Major organ failure26.1% (12)20.0% (1)25.0% (1)38.5% (10)34.3% (12)0.47
Acute respiratory distress4.4% (2)0.0% (0)0.0% (0)3.9% (1)2.9% (1)1.0
Acute respiratory failure4.4% (2)0.0% (0)0.0% (0)3.9% (1)2.9% (1)1.0
Cholecystitis2.2% (1)0.0% (0)0.0% (0)3.9% (1)2.9% (1)1.0
Mesh infection4.4% (2)0.0% (0)0.0% (0)3.9% (1)2.9% (1)1.0
ventral hernia2.2% (1)0.0% (0)25.0% (1)3.9% (1)5.7% (2)0.58
Wound infection2.2% (1)0.0% (0)0.0% (0)7.7% (2)5.7% (2)0.58
Candida sepsis4.4% (2)0.0% (0)0.0% (0)0.0% (0)0.0% (0)0.50
Sepsis6.5% (3)0.0% (0)25.0% (1)11.5% (3)11.4% (4)0.46
Wound healing Disorder2.2% (1)0.0% (0)0.0% (0)7.7% (2)5.7% (2)0.58
Other30.4% (14)0.0% (0)75.0% (3)26.9% (7)28.6% (10)1.0